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Background: Sentinel lymph node (SLN) biopsy plays a major role in the surgical management of primary
breast cancer. The aim of this study was to assess the diagnostic accuracy of the assessment of axillary
frozen sections of SLNs for micrometastasis diagnosis.
Patients and methods: This study focused on 250 SLNs from 137 patients. Each lymph node was fully
analyzed by frozen section. After ﬁxation, serial sections were cut and stained by hematoxylin and eosin
(HE) and for pan-cytokeratins by immunohistochemistry (IHC).
Results: Tumor cells were detected in 57 SLNs, 37 on frozen sections and 20 on controls. Of these 57
positive SLNs, 38 contained metastases, 9 contained micrometastases and 10 contained isolated tumor
cells. The speciﬁcity and positive predictive value of SLN frozen sections for micrometastasis was 100%.
The sensitivity was 83.3% for metastasis, 40% for micrometastasis; the false-negative rate was 16.7% for
metastasis and 60% for micrometastasis.
Conclusion: Analysis of frozen section of SLNs is an accurate method for metastasis detection, allowing
concurrent axillary dissection when positive. The protocol for SLN analyses described herein shows good
sensitivity for micrometastasis detection.
© 2014 Published by Elsevier Ltd on behalf of Surgical Associates Ltd.1. Introduction
Axillary lymph node status remains one of the most important
prognostic factors in primary breast carcinoma, despite the devel-
opment of a range of other prognostic markers [1]. The sentinel
lymph node (SLN) biopsy technique was introduced to permit an
accurate staging of the axillary lymph node status for T1-2, N0
breast carcinoma [2,3]. Examination of the SLN by frozen section is
known to be less accurate than analysis of permanent sections, but
allows re-intervention for axillary lymph node dissection to be
avoided if metastases are detected. Some controversies remain in
the literature concerning the utility of routine SLN frozen section in
breast cancer. Some centers prefer touch imprinting or delayed
histopathologic of analysis. Recently, studies have focused on the, 05100 Terni, Italy.
guinetti).
f of Surgical Associates Ltd.implication of SLN micrometastasis [3e6], Viale et al. found that
axillary lymph node metastases were present in 21.6% of cases, and
they discussed whether axillary lymph node dissection should
under taken in cases of sentinel lymph nodemicrometastasis [1]. In
our institution, SLN biopsy frozen sectionwas introduced in the late
2010s, in a multidisciplinary setting, in order to avoid unnecessary
axillary lymph node dissection. At the end of 2011, wemodiﬁed our
SLN protocol following the recommendation of Turner et al. [3]. The
aim of this study was to estimate the sensitivity, speciﬁcity, nega-
tive predictive value and false-negative rate of frozen section in the
detection of SLN micrometastasis.
2. Patients and methods
2.1. Patients
For this retrospective study, we collected 250 SLNs from 137
patients with breast carcinoma who underwent SLN mapping
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for frozen section. The median number of SLNs examined per pa-
tient was 2.45 (range 1e7). There were 9 cases of mastectomy and
128 cases of lumpectomy. In 10 cases, no invasive carcinomas were
retrieved, but ductal carcinoma in situwas present in 7 cases and no
residual tumor was found in 3 cases of neo-adjuvant therapy. A
total of 250 SLNs were thus included in this study.
2.2. Histopathological analysis of the tumor
The relevant clinicopathological characteristics were tumor
type, Bloom- Richardson grade, lympho vascular invasion, peri-
neural invasion, proliferation index (MIB-1), estrogen and proges-
terone receptor status as analyzed by immunohistochemistry and
scored with Allred score [4], HER2/neu ampliﬁcation assessed by
ﬂuorescence in situ hybridization (FISH) analysis and gene ampli-
ﬁcation determined by a ratio of HER2/CEP17 > 2.
2.3. Histhopathological analysis of the lymph nodes
Axillary SLNs were analyzed by frozen section intra-operatively,
using a protocol modiﬁed from Turner et al. [3]. Lymph nodes less
than 4 mm in diameter were included in totality for frozen section;
lymph nodes between 5 and 7 mm in diameter were bisected and
each part was included for frozen section; lymph nodes equal or
greater than 8 mm in diameter were cut into 4 mm slices and
totally included for frozen section. Control sections were performed
after formalin ﬁxation and parafﬁn embedding; every parafﬁn
block was totally cut into 4 mm-thick serial sections at 250 mm in-
tervals. These sections were stained with hematoxylin and eosin
(HE). If no metastasis was visible on HE staining, immunochemistry
was performed on 3 sections separated by 500 mm as follows. A
pool of monoclonal mouse anti-human cytokeratin antibodies
(Monoclonal Mouse Anti-Human Cytokeratin 7 Clone OV-TL) was
used from Dako, Baar, Switzerland (AE1-AE3, M3515; dilution
1:100) and from BioGenex, San Ramon, USA (anti-cytokeratin 8 and
18 (5D3), AM131; dilution 1:25), with microwave antigen retrieval
and 3,3-diaminobenzidine as chromogen. Metastasis was deﬁned
as a tumor inﬁltrate larger than 2 mm andmicrometastasis deﬁned
as tumor involvement 0.2 mm but <2 mm. The presence of iso-
lated tumor cells (ITCs) was deﬁned as existence of single tumor
cells or small cell clusters not greater than 0.2 mm according to the
AJCC TNM Classiﬁcation of Malignant Tumors, 6th Edition [5].
3. Results
3.1. SLN metastases
Over a two year period, we performed the same SLN protocol as
described in the Materials and Methods section. Of a total of 250
SLNs retained for this study, 56 were positive (22.7%): 36 were
diagnosed using the intraoperative frozen section (65%) and 20
positive SLNs were found on control sections (35%). Metastases
greater than 2mmwere present in 37 SLNs: 31 diagnosed on frozen
section and 6 on control sections. SLN metastasis that were not
diagnosed on frozen sectionwere considered as false-negative SLN,
so 6 out of 37. Of the six false-negative SLN frozen sections, in 3
cases the slides were sub-optimal, rendering a correct diagnosis
impossible; in 2 cases, the metastases were undiagnosed on frozen
section and in 1 case the metastasis appeared only at the levels
performed for the control sections. In two cases of lobular carci-
noma the lymph node metastasis were not seen but were revealed
with cytokeratin IHC. Micrometastases were diagnosed in 9 SLNs: 4
on frozen section and 5 on control sections. There was 5 false-
negative SLN on frozen section. The size of the micrometastasesranged from 0.25 mm to 1.9 mm. Of the 5 cases diagnosed on
control sections, 2 were found at successive levels and 4 only by
IHC. For the 2 cases diagnosed at successive levels, micrometastases
were ﬁrst found in Section 1 of 5, Section 2 of 4 and Section 7 of 7;
this one illustrates the usefulness of serial sections for micro-
metastasis detection. ITCs were found in 10 cases, two on frozen
sections and 8 cases on controls sections, only by IHC. There was 7
false-negative SLN on frozen section.
3.2. Sensitivity and speciﬁcity
The speciﬁcity of frozen section analysis was 100% for metas-
tasis, micrometastasis and ITC. The sensitivity of frozen section in
metastasis was 83.3% and decreased to 40% formicrometastasis and
18.2% for ITC. The negative predictive value was 91.9% for metas-
tasis, 80.6% for micrometastasis and 70% for ITCs. The false-negative
ratewas 16.7% formetastasis, 60% formicrometastasis and 81.8% for
ITCs. There was no false positive case.
3.3. Axillary lymph node dissection
An axillary lymph node dissection was performed in 22 out of
the 25 patients (89.3%) with SLN metastasis: 20 during the same
surgery and 2 during a second operation. In 8 cases, there were
positive axillary lymph nodes. Three out of the seven patients with
SLN micrometastasis underwent axillary dissection: 1 during the
same operation and 2 in a second intervention. All axillary lymph
nodes were negative. Only 1 out of the 9 patients with SLN ITCs
underwent axillary lymph node dissection during the same oper-
ating time, which one was positive.
3.4. Extra capsular SLN inﬁltration
Interestingly, of the 24 axillary dissections performed [25], 9
patients had axillary lymph node metastasis. Of them, in 6 cases
(63.6%) the SLN had metastatic extra capsular growth and adipose
tissue inﬁltration. Furthermore, in the 15 cases of negative axillary
dissection, only 3 cases (22.2%) had SLN metastatic extra capsular
growth and adipose tissue inﬁltration.
4. Discussion
While the detection of rate of SLN and the accuracy of SLN
histology as a predictor of axillary lymph node status have been
extensively studied [6,8e10], information about the utility of intra-
operative frozen section for SLN micrometastasis is sparse. In this
study of 278 SLN frozen sections, 63 SLNs were inﬁltrated by tu-
moral cells including 66.7% SLN metastasis, 15.9% of SLN micro-
metastasis and 17.4% of ITCs. We demonstrated a sensitivity of
83.3% for this method in detecting metastasis, but a lower sensi-
tivity, 40%, for micrometastasis. Previous studies published on the
sensitivity of frozen section for micrometastasis conﬁrmed the
variable rate, ranging from 10% to 61%. This large variation depends
on the different histopathological techniques used for frozen sec-
tion analysis, including the cutting intervals, the number of sections
and the use of IHC on control, as well as if perioperative IHC was
used [6]. In our opinion, IHC during intraoperative SLN examination
is time consuming and not practicable for most small institutions.
Recently, reverse-transcription polymerase chain reaction (RT-PCR)
assay for cytokeratin-19 and mammaglobin are beginning to be
evaluated during intraoperative SLN exam [7e9]. At the present
time, no clear international directive exists regarding the use of
frozen section. In 2004, the European Working Group for Breast
Screening Pathology (EWGBP) reported a high degree of variability
among European pathology institutes for SLN examination [10].
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which are in accord with our protocol [11,12]. They stipulated that
intraoperative assessment of SLN can be carried out by frozen
section and/or imprinting cytology based on institutional resources
and preferences, since both methods have similar sensitivity and
speciﬁcity for metastasis detection. Our SLN protocol for frozen and
permanent sections consists of 4 mm slices for frozen section
analysis followed by consecutive sections at 250 mm intervals for
histology and IHC until thematerial is exhausted.We show that this
protocol results in good sensitivity and speciﬁcity compared to the
literature for detection of micrometastasis. For metastasis, sensi-
tivity was of 83.3%, while it was 40% for micrometastasis, which is
better than the published mean of 30%. After ﬁxation, analysis of
serial sections resulted in detection of 50% more cases of SLN
micrometastasis. In one case micrometastasis was obtained only on
the last section, which is an argument for exhaustion of the lymph
node on permanent sections. Furthermore, IHC increased the
sensitivity, resulting in the diagnosis of 50% more micrometastasis,
conﬁrming data of the literature [13,14,26e32] and supporting the
usefulness of IHC on HE-negative lymph node samples. With
regards to axillary lymph node dissection, this was positive in 10/25
cases of SLN metastasis, 0/3 cases in SLN micrometastasis and 1/1
case in SLN ITC. These results should be interpreted with caution
because this small series of axillary lymph node dissection for
micrometastasis and ITC is not representative of the literature data
with an involvement of 3%e21% for micrometastasis [1,15] and
from 1.6% to 14% for ITC [1,16]. An important point is the higher
prevalence of axillary lymph node metastasis in cases of SLN
showing capsular rupture (63.6% versus 22.2%), supporting the
recent evidence from the literature concerning the biological sig-
niﬁcance, in breast carcinoma, of perilymph node fat tumoral in-
vasion and an increased axillary lymph node metastasis [15e33].
5. Conclusion
Frozen section analysis is a reliable and safe procedure for
diagnosis of SLNmetastasis, allowing immediate axillary dissection
in a one-stage surgical procedure. Furthermore, our SLN protocol
demonstrated a good sensitivity for micrometastasis detection,
although as yet, this is not a reliable indication of axillary lymph
nodes dissection.
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